Special and primary election results for State House District 34B primary, St. Paul City Council and more

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

(AP) - Minneapolis-based medical device maker
Medtronic says it will expand the company's heart valve business at
a price of more than $1 billion.


      Medtronic says it will pay $700 million for Irvine, Calif.-based
Corevalve and $325 million for Israeli firm Ventor Technologies.
Both companies make replacement heart valves.


      Corevalve's technology has been implanted in 2,600 patients
worldwide, though it has not yet been cleared for use by the Food
and Drug Administration.


      Rather than performing open-heart surgery, the company's system
allows a surgeon to insert a replacement heart valve through a
small incision in the leg artery.


      Ventor Technologies' products are especially designed for
patients with heart valves that don't open completely, but who are
too sick to undergo surgery.

Gallery

FDA approves Medtronic device to relieve OCD

Medtronic stock rises after positive earnings report

Business and Economic News

Health

Minneapolis-based medical device maker
Medtronic says it will expand the company's heart valve business by acquiring two firms that make replacement heart valves -- at a price of more than $1 billion.

Medtronic spends $1B on heart valve acquisitions

Go Deeper.

Like this?